TY  -  
T1  - Effect of clinical inertia and trial participation in younger and older adults with diabetes having comorbidities and progressive complications 
SN  -  /  
UR  - http://hdl.handle.net/10138/332452 
T3  -  
A1  - Strain, William David; Paldánius, Päivi Maria 
A2  -  
PB  -  
Y1  - 2020 
LA  - eng 
AB  - Aim: Clinical inertia is a multifactorial phenomenon, with contributing factors from people with diabetes and their healthcare team. It is widely cited that clinical inertia is minimised by participation in clinical trials. We assessed whether trial participation per se improves metabolic parameters in people with diabetes, or a specific focus on glycaemia is required. Methods: We compared improvement in glycaemic control in a pooled set of people assigned to the "placebo" arm from 25 glycaemia-... 
VO  -  
IS  -  
SP  -  
OP  -  
KW  - 3121 General medicine, internal medicine and other clinical medicine; Chronic kidney disease; Clinical inertia; Placebo effect; Randomised controlled trials; Type 2 diabetes mellitus; TREATMENT INTENSIFICATION; POSITION STATEMENT; ELDERLY-PATIENTS; TYPE-2; MANAGEMENT; PEOPLE; TIME; CARE; ASSOCIATION; THERAPY 
N1  -   
PP  -  
ER  -